Trademark: 97401100
Word
DURECT
Status
Pending
Status Code
730
Status Date
Wednesday, November 29, 2023
Serial Number
97401100
Mark Type
4000
Filing Date
Monday, May 9, 2022
Published for Opposition
Tuesday, April 4, 2023
Trademark Owner History
Durect Corporation - Owner At Publication
Classifications
5 Pharmaceutical preparations for the prevention and treatment of metabolic diseases and disorders, diseases and disorders of the endocrine system, inflammatory diseases and disorders, autoimmune diseases and disorders, cancer, neurological diseases and disorders, central nervous system diseases and disorders, acute organ injury, epigenetic diseases and disorders, and DNA methyltransferase (DNMT)-associated diseases and disorders
Trademark Events
Apr 3, 2024
Teas Statement Of Use Received
Nov 30, 2023
Notice Of Approval Of Extension Request E-Mailed
Nov 29, 2023
Sou Extension 1 Granted
Nov 29, 2023
Sou Extension 1 Filed
Nov 28, 2023
Sou Teas Extension Received
May 30, 2023
Noa E-Mailed - Sou Required From Applicant
Apr 4, 2023
Official Gazette Publication Confirmation E-Mailed
Apr 4, 2023
Published For Opposition
Mar 15, 2023
Notification Of Notice Of Publication E-Mailed
Mar 2, 2023
Approved For Pub - Principal Register
Feb 27, 2023
Assigned To Examiner
May 13, 2022
New Application Office Supplied Data Entered
May 12, 2022
New Application Entered
IMPACT PLATFORM
BF
Trademark Alertz updated from USPTO on 2030-01-24

Trademark Alertz ™ - GRJR PTY LTD 2024 - Privacy Policy - Terms of Use

The information provided on Trademark Alertz is not legal or professional advice. Information may have been obtained from third parties and may contain errors. You must make your own enquiries and seek independent advice from relevant industry professionals before acting or relying on any information from Trademark Alertz. All trade mark information has been obtained from and made publicly available by The United States Patent and Trademark Office (USPTO). Copyright of the trademark data resides with USPTO. www.uspto.gov